Human Growth Hormone Drug Market 2024| By Key Players, Share,
and Forecast to 2031

The global human growth hormone drug market is anticipated
to grow at a significant CAGR during the forecast period (2024-2031).
Somatotropin, or human growth hormone, is a peptide hormone that promotes
growth, cell reproduction, and cell regeneration. The pituitary gland does not
manufacture enough concentrations of human growth hormones in humans, resulting
in growth hormone insufficiency. Subcutaneous injections of recombinant human
growth hormones are used to treat this deficiency. Growth hormone insufficiency
can also be caused by genetic illnesses including Prader-Willi syndrome and
Turner syndrome, which can lead to delayed puberty and shorter-than-average
height. The development of recombinant human growth hormone treatments, the
rise in pituitary dysfunction cases, and the rise in off-label use of human
growth hormones are all key factors driving the market growth.

Get Free Sample link @ https://www.omrglobal.com/request-sample/human-growth-hormone-drug-market

During the forecast period, the turner syndrome segment is
expected to have a significant market share in the global human growth hormone
drug market. Turner syndrome is a female-specific chromosomal disease that is
characterized by the deletion of one of the X chromosomes, either partially or
completely. Turner syndrome is characterized by a wide neck and a receding or
indistinct hairline, as well as a proclivity for high blood pressure, mild eye
difficulties, drooping eyelids, and an underactive thyroid gland. The market is
expected to propel as various public and private organizations raise awareness
about the early diagnosis and treatment of Turner syndrome. For instance,
Turner Syndrome Support Society UK, Turner Syndrome Society of the US, and
Turner Syndrome Foundation, mark "Turner Syndrome Awareness Month" in
February every year and have started a nationwide effort to raise awareness
about the condition.

Full report of Human Growth Hormone Drug Market available @
https://www.omrglobal.com/industry-reports/human-growth-hormone-drug-market

The key players operating in the global human growth hormone
drug market include Eli Lilly and Co., Novo Nordisk A/S, and Pfizer Inc., among
others. The market players are considerably contributing to the market growth
by the adoption of various strategies including mergers & acquisitions,
partnerships and collaborations, and new product launches, to stay competitive
in the market. For instance, Pfizer Inc. began a Phase III research trial in
February 2021 to assess the efficacy and safety of somatropin in a group of
Japanese patients with Prader-Willi Syndrome (PWS). In October 2020, Erasmus
Medical Center, in collaboration with Pfizer, the Foundation for Prader-Willi
Research, and the Prader-Willi Fonds, launched a Phase III clinical trial to
evaluate the impact of growth hormone treatment (Genotropin) on physical and
psychosocial health in adults with Prader-Willi syndrome who are 30 years or
older.

Market Coverage

Segment Covered- 

• By
  Application 


• By
  Distribution Channel

Regions Covered-

• North
  America


• Europe


• Asia-Pacific


• Rest
  of the World

Competitive Landscape- Eli Lilly and Co., Novo
Nordisk A/S, and Pfizer Inc., among others.

• Key
  questions addressed by the report


• What
  is the market growth rate?


• Which
  segment and region dominate the market in the base year?


• Which
  segment and region will project the fastest growth in the market?


• How
  has COVID-19 impacted the market?

o             Deviation
from the pre-COVID-19 forecast

o             Most
affected region and segment

• Who
  is the leader in the market?


• How
  players are addressing challenges to sustain growth?


• Where
  is the investment opportunity?

Global Human Growth Hormone Drug Market Report by Segment

By Application

• Growth
  Hormone Deficiency


• Turner
  Syndrome


• Idiopathic
  Short Stature


• Prader-Willi
  Syndrome


• Other 

By Distribution Channel

• Hospitals
  and Retail Pharmacies


• Online
  Pharmacies

Reasons to Buying From us -



1. We cover more than 15 major industries, further segmented into more than 90
sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after
purchasing your report.

For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/human-growth-hormone-drug-market

Media Contact:



Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research



About Orion Market Research



Orion Market Research (OMR) is a market research and consulting company known
for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services. The company also offers Digital Marketing services through its
subsidiary OMR Digital and Software development and Consulting Services through
another subsidiary Encanto Technologies.